Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Wood

Showing results (331-340 of 369) with videos related to

Pageof 37
Sort By:
The Lancet. HIV|November 6, 2016
Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE studyMark A Boyd, Janaki Amin, Patrick W G Mallon, et al.
Plos One|January 26, 2016
Real-Time Investigation of Tuberculosis Transmission: Developing the Respiratory Aerosol Sampling Chamber (RASC)Robin Wood, Carl Morrow, Clifton E Barry, et al.
Plos Medicine|January 27, 2011
Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studiesHaileyesus Getahun, Wanitchaya Kittikraisak, Charles M Heilig, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 2021
2021 update to HIV-TRePS: a highly flexible and accurate system for the prediction of treatment response from incomplete baseline information in different healthcare settingsAndrew D Revell, Dechao Wang, Maria-Jesus Perez-Elias, et al.
Plos Medicine|November 22, 2013
When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern AfricaMichael Schomaker, Matthias Egger, James Ndirangu, et al.
Journal of the International AIDS Society|July 9, 2020
Trends in CD4 and viral load testing 2005 to 2018: multi-cohort study of people living with HIV in Southern AfricaElizabeth Zaniewski, Cam H Dao Ostinelli, Frédérique Chammartin, et al.
Antimicrobial Agents and Chemotherapy|September 10, 2015
Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal MeningitisTihana Bicanic, Christian Bottomley, Angela Loyse, et al.
Plos Pathogens|February 1, 2021
Capture and visualization of live Mycobacterium tuberculosis bacilli from tuberculosis patient bioaerosolsRyan Dinkele, Sophia Gessner, Andrea McKerry, et al.
Plos Medicine|January 27, 2011
Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan AfricaMatthias Egger, Ben D Spycher, John Sidle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2020
Cost-effectiveness of a Novel Lipoarabinomannan Test for Tuberculosis in Patients With Human Immunodeficiency VirusKrishna P Reddy, Claudia M Denkinger, Tobias Broger, et al.
Pageof 37

Showing results (331-340 of 369) with videos related to

Sort By:
Pageof 37
The Lancet. HIV|November 6, 2016
Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE studyMark A Boyd, Janaki Amin, Patrick W G Mallon, et al.
Plos One|January 26, 2016
Real-Time Investigation of Tuberculosis Transmission: Developing the Respiratory Aerosol Sampling Chamber (RASC)Robin Wood, Carl Morrow, Clifton E Barry, et al.
Plos Medicine|January 27, 2011
Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studiesHaileyesus Getahun, Wanitchaya Kittikraisak, Charles M Heilig, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 2021
2021 update to HIV-TRePS: a highly flexible and accurate system for the prediction of treatment response from incomplete baseline information in different healthcare settingsAndrew D Revell, Dechao Wang, Maria-Jesus Perez-Elias, et al.
Plos Medicine|November 22, 2013
When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern AfricaMichael Schomaker, Matthias Egger, James Ndirangu, et al.
Journal of the International AIDS Society|July 9, 2020
Trends in CD4 and viral load testing 2005 to 2018: multi-cohort study of people living with HIV in Southern AfricaElizabeth Zaniewski, Cam H Dao Ostinelli, Frédérique Chammartin, et al.
Antimicrobial Agents and Chemotherapy|September 10, 2015
Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal MeningitisTihana Bicanic, Christian Bottomley, Angela Loyse, et al.
Plos Pathogens|February 1, 2021
Capture and visualization of live Mycobacterium tuberculosis bacilli from tuberculosis patient bioaerosolsRyan Dinkele, Sophia Gessner, Andrea McKerry, et al.
Plos Medicine|January 27, 2011
Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan AfricaMatthias Egger, Ben D Spycher, John Sidle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2020
Cost-effectiveness of a Novel Lipoarabinomannan Test for Tuberculosis in Patients With Human Immunodeficiency VirusKrishna P Reddy, Claudia M Denkinger, Tobias Broger, et al.
Pageof 37